Overview

Global Peripheral Vascular Devices Market is estimated to value over USD 14.8 billion by 2026 end and register a CAGR of over 5.8% during the forecast period 2019 to 2026.

 

Peripheral arterial disease (PAD) is caused by blocking or narrowing of the blood vessels owing to the build-up of plaque. This condition can result in aneurysms, kidney diseases, the death of tissue, heart stroke in cases when left untreated. As per the National Institute of Health, one in concerning people over 50 years, one in every 20 American has PAD. It has influenced over eight to 12 million people in the U.S, particularly to those over the age of 50. 

 

As the population is constantly increasing, the incidences of disease are rising which could proliferate from over 10 million to reach an overall of 20 million worldwide by 2050. With the ageing of the population around the world, it possibly seems that PAD will be normalised in the upcoming years. Therefore, as per the statistics have revealed, the number of peripheral arterial disease is rising at a quicker pace, which is gradually driving the peripheral vascular devices market. Other factors like the growing demand for minimally-invasive surgeries for peripheral arterial disease, in particular, lifestyle changes, technological advancements and increase in the geriatric population have expanded the peripheral vascular devices market size.

 

Based on type, the peripheral vascular devices market is bifurcated into embolic projection devices, peripheral guidewires, peripheral stents grafts, peripheral venous thrombectomy device, vena cava filters, angioplasty catheters and PTA balloons. Peripheral vascular stents graft accounts for the largest peripheral vascular devices market share. Angioplasty catheter segment is predicted to showcase substantial growth over the forecast period. 

 

Geographically, the market is fragmented into North America, Europe, Asia Pacific and the rest of the world. North America dominates the peripheral vascular devices market which is followed by the Europe region. The Asia Pacific region is anticipated to proliferate during the forecast period owing to the increasing prevalence of peripheral vascular diseases. Manufacturers of peripheral vascular devices are slowly adopting integral developmental strategies to create innovative devices. Many clinical trials are currently in progress to increase device efficacy and safety.

 

Key market players in the peripheral vascular devices market are Medtronic (Ireland), Becton, Dickinson and Company (US), Terumo Corporation (Japan), Boston Scientific Corporation (US), Abbott (US), Cardinal Health (US), iVascular (Spain), B. Braun Melsungen (Germany), Biosensors International Group (Singapore), BIOTRONIK SE & Co. KG (Germany), Penumbra Inc.

Global Peripheral Vascular Devices Market Segmentation:

By Type

· Angioplasty Balloons

o Old/Normal Balloons

o Cutting and Scoring Balloons

o Drug-Eluting Balloons

· Angioplasty Stents

o Drug-Eluting Stents

o Bare-Metal Stents

§ Balloon-Expandable Stents

§ Self-Expandable Stents

· Catheters

o Angioplasty Catheters

o Guiding Catheters

o IVUXS/OCT Catheters

· Endovascular Aneurysm Repair Stent Graft

o Abdominal Aortic Aneurysm Stent Grafts

o Thoracic Aortic Aneurysm Stent Grafts

· Inferior Vena Cava Filters

o Retrievable Filters

o Permanent Filters

· Plaque Modification Devices

o Atherectomy Devices

o Thrombectomy Devices

· Hemodynamic Flow Alteration Devices

o Embolic Protection Devices

o Chronic Total Occlusion (CTO)

  devices

· Others

o Guidewires

o Vascular Closure Devices

o Introducer Sheaths

o Balloon Inflation Devices

 

By Region

· North America

· Europe

· Asia Pacific

· Rest of the World

 

FutureWise Key Takeaways:

• Growth prospects

• SWOT analysis 

• Key trends 

• Key data-points affecting market growth 

 

Objectives of the Study:

• To provide with an exhaustive analysis on the global peripheral vascular devices market by type and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market 
• To predict the market size, in key regions (along with countries)— Europe, North America, Asia Pacific and the rest of the world
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Table of Contents

1 Introduction 

    1.1 Objectives of the Study 

    1.2 Market Definition 

           1.2.1 Markets Covered

           1.2.2 Regional Coverage

           1.2.3 Years Considered for the Study

    1.3 Currency 

    1.4 Limitations 

    1.5 Stakeholders 

2 Research Methodology 

    2.1 Secondary Data 

           2.1.1 Key Data From Secondary Sources

    2.2 Primary Data 

           2.2.1 Key Data From Primary Sources

    2.3 Market Size Estimation 

           2.3.1 Bottom-Up Approach

           2.3.2 Top-Down Approach

    2.4 Market Breakdown and Data Triangulation 

    2.5 Assumptions for the Study 

3 Executive Summary 

4 Premium Insights 

    4.1 Peripheral Vascular Devices Market Overview 

    4.2 North America: Angioplasty Stents Market (2018) 

    4.3 Geographical Snapshot of the Peripheral Vascular Devices Market 

5 Market Overview 

    5.1 Introduction 

    5.2 Market Dynamics 

           5.2.1 Drivers

                    5.2.1.1 Rapid Growth in the Geriatric Population and the Subsequent Increase in the Prevalence of Peripheral Vascular Diseases

                    5.2.1.2 Product Approvals

                    5.2.1.3 Increasing Prevalence of Diabetes

           5.2.2 Restraints

                    5.2.2.1 Product Failures and Recalls

           5.2.3 Opportunities

                    5.2.3.1 Emerging Markets

           5.2.4 Challenges

                    5.2.4.1 Availability of Alternative Treatments

6 Angioplasty Balloons Market, By Type 

    6.1 Introduction 

    6.2 Old/Normal Balloons 

           6.2.1 Old/Normal Balloons Will Continue to Dominate the Angioplasty Balloons Market in 2024

    6.3 Cutting and Scoring Balloons 

           6.3.1 Cutting Balloons are Used to Treat Atherosclerosis

    6.4 Drug-Eluting Balloons 

           6.4.1 Drug-Eluting Balloons to Witness the Highest Growth in the Angioplasty Balloons Market During the Forecast Period

7 Angioplasty Stents Market, By Type 

    7.1 Introduction 

    7.2 Drug-Eluting Stents 

           7.2.1 Drug-Eluting Stents to Witness Higher Adoption Primarily Due to the Reduced Restenosis Rate Associated With These Products

    7.3 Bare-Metal Stents 

           7.3.1 Increasing Use of Drug-Eluting Stents to Restrain Market Growth

           7.3.2 Bare-Metal Stents, By Delivery Platform

                    7.3.2.1 Balloon-Expandable Stents

                    7.3.2.2 Self-Expandable Stents

8 Catheters Market, By Type

    8.1 Introduction 

    8.2 Angiography Catheters 

           8.2.1 Angiography Catheters to Dominate the Catheters Market During the Forecast Period

    8.3 Guiding Catheters 

           8.3.1 Guiding Catheters to Account for the Second-Largest Share of the Catheters Market During the Forecast Period

    8.4 IVUS/OCT Catheters 

           8.4.1 IVUS/OCT Catheters Segment to Register the Highest Growth Rate During the Forecast Period

9 Endovascular Aneurysm Repair Stent Grafts Market, By Type 

    9.1 Introduction 

    9.2 Abdominal Aortic Aneurysm Stent Grafts 

           9.2.1 Abdominal Aortic Aneurysm Stent Grafts to Dominate the Market During the Forecast Period

    9.3 Thoracic Aortic Aneurysm Stent Grafts 

           9.3.1 Increasing Incidence of Thoracic Aortic Aneurysms to Drive Market Growth in the Coming Years

10 Inferior Vena Cava Filters Market, By Type 

     10.1 Introduction 

     10.2 Retrievable Filters 

             10.2.1 Retrievable Filters Segment to Register A Higher Growth Rate During the Forecast Period

     10.3 Permanent Filters 

             10.3.1 Risks Associated With Permanent Filters to Hamper Their Sales During the Forecast Period

11 Plaque Modification Devices Market, By Type 

     11.1 Introduction 

     11.2 Atherectomy Devices 

             11.2.1 Increasing Incidence of Atherosclerosis as A Result of the Rising Global Prevalence of Obesity—A Key Market Driver

     11.3 Thrombectomy Devices 

             11.3.1 Growing DVT Incidence to Drive the Adoption of Thrombectomy Devices

12 Hemodynamic Flow Alteration Devices Market, By Type 

     12.1 Introduction 

     12.2 Embolic Protection Devices 

             12.2.1 Increasing Investments in New Technology Development and the Growing Number of Regulatory Approvals for These Devices to Drive Market Growth

     12.3 Chronic Total Occlusion (CTO) Devices 

             12.3.1 Increasing Investments in the Development of CTO Devices to Drive Market Growth

 

13 Other Peripheral Vascular Devices Market, By Type 

     13.1 Introduction 

     13.2 Guidewires 

     13.3 Vascular Closure Devices 

     13.4 Introducer Sheaths 

     13.5 Balloon Inflation Devices 

 

14 Peripheral Vascular Devices Market, By Region 

     14.1 Introduction 

     14.2 North America 

             14.2.1 US

                        14.2.1.1 Favorable Reimbursement Scenario Ensures Device Adoption in the Us

             14.2.2 Canada

                        14.2.2.1 Rising Prevalence of Target Diseases Will Drive Market Growth

     14.3 Europe 

             14.3.1 Germany

                        14.3.1.1 Increase in Geriatric and Obese Populations Will Contribute to Device Demand

             14.3.2 France

                        14.3.2.1 Incidence of Pe and DVT Will Increase, Corresponding to Growth in France’s Geriatric Population

             14.3.3 UK

                        14.3.3.1 Increasing Incidence of Peripheral Vascular Diseases to Support Market Growth in the Uk

             14.3.4 Spain

                        14.3.4.1 Rising Geriatric Population to Increase the Demand for Peripheral Vascular Devices in Spain

             14.3.5 Italy

                        14.3.5.1 Increasing Health Expenditure and Rising Diabetes Prevalence are the Major Factors Driving Market Growth in Italy

             14.3.6 Rest of Europe

     14.4 Asia Pacific 

             14.4.1 Japan

                        14.4.1.1 Presence of A Large Geriatric Population – A Major Factor Supporting Market Growth in Japan

             14.4.2 China

                        14.4.2.1 Growing Target Patient Population in China to Drive Market Growth

             14.4.3 India

                        14.4.3.1 Increasing Prevalence of Diabetes to Drive the Adoption of Peripheral Vascular Devices

             14.4.4 Rest of Asia Pacific

     14.5 Rest of the World 

             14.5.1 Latin America

                        14.5.1.1 Growing Geriatric Population and the Subsequent Increase in the Prevalence of Peripheral Artery Diseases to Drive Market Growth

             14.5.2 Middle East & Africa

                        14.5.2.1 Increasing Prevalence of Diabetes to Drive Market Growth

15 Competitive Landscape 

     15.1 Overview 

     15.2 Market Share Analysis

     15.3 Competitive Scenario 

             15.3.1 Product Launches and Approvals

             15.3.2 Acquisitions, 2015–2018

             15.3.3 Agreements, 2015–2018

             15.3.4 Expansions, 2015–2018

     15.4 Competitive Leadership Mapping 

             15.4.1 Vendor Inclusion Criteria

             15.4.2 Visionary Leaders

             15.4.3 Innovators

             15.4.4 Dynamic Differentiators

             15.4.5 Emerging Companies

     15.5 Competitive Leadership Mapping for Start-Ups 

             15.5.1 Progressive Companies

             15.5.2 Starting Blocks

             15.5.3 Responsive Companies

             15.5.4 Dynamic Companies

16 Company Profiles 

     16.1 Medtronic 

     16.2 Boston Scientific Corporation 

     16.3 Abbott Laboratories 

     16.4 Becton, Dickinson and Company 

     16.5 Terumo Corporation 

     16.6 Cordis (A Subsidiary of Cardinal Health, Inc.) 

     16.7 B. Braun Melsungen AG 

     16.8 Ivascular 

     16.9 Biosensors International Group Ltd. 

     16.10 Biotronik 

     16.11 Penumbra, Inc.

 

Chapter 12 Research Finding and Conclusion 

 

Chapter 13  Research Methodology 

 

Chapter 14  Research Data Source  

 

Tables

Figures